Characteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer

计划入组 128 人 · 首次发布于 2024 年 4 月 16 日

Drug-Induced Liver Injury (DILI) Network Retrospective

计划入组 400 人 · 首次发布于 2006 年 8 月 4 日

Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)

计划入组 52 人 · 首次发布于 2010 年 11 月 1 日

L-Dilinoleoyllecithin

C₄₄H₈₀NO₈P

Lithium succinate

C₄H₄Li₂O₄

Lithium carbonate(Carbolith, Lithane, Lithmax, Lithobid)

CLi₂O₃ · Rx

Dali Pharmaceutical Co.,Ltd

INNER MONNGOLIA YILI INDUSTRIAL GROUP CO.,LTD.

China

CN Bio Expands FDA-Recognized DILI Assay with Cross-Species Models to Improve Drug Safety Predictions

Expert Consensus Provides Guidance on Drug-Induced Liver Injury in Oncology Trials

SKYCLARYS PASS Registry to Monitor Long-Term Safety of Omaveloxolone in Friedreich Ataxia